A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy. [electronic resource]
Producer: 20161027Description: 100-6 p. digitalISSN:- 1476-5608
- Adult
- Aged
- Disease-Free Survival
- Docetaxel
- Humans
- Indoles -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Recurrence, Local -- drug therapy
- Prednisone -- administration & dosage
- Prostate-Specific Antigen -- metabolism
- Prostatectomy
- Prostatic Neoplasms -- drug therapy
- Pyrroles -- administration & dosage
- Quality of Life
- Salvage Therapy
- Sunitinib
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.